{
    "clinical_study": {
        "@rank": "149780", 
        "acronym": "ALLY 2", 
        "arm_group": [
            {
                "arm_group_label": "Arm 1: Cohort 1a-Treatment-naive-12 weeks", 
                "arm_group_type": "Experimental", 
                "description": "Daclatasvir 30, 60 or 90 mg tablet and Sofosbuvir 400 mg tablet orally once daily for 12 weeks"
            }, 
            {
                "arm_group_label": "Arm 2: Cohort 1b-Treatment-naive-8 weeks", 
                "arm_group_type": "Experimental", 
                "description": "Daclatasvir 30, 60 or 90 mg tablet and Sofosbuvir 400 mg tablet orally once daily for 8 weeks"
            }, 
            {
                "arm_group_label": "Arm 3: Cohort 2-Treatment Experineced-12 weeks", 
                "arm_group_type": "Experimental", 
                "description": "Daclatasvir 30, 60 or 90 mg tablet and Sofosbuvir 400 mg tablet orally once daily for 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "To study the combination of Daclatasvir and Sofosbuvir for the treatment of HCV/ HIV\n      Coinfection"
        }, 
        "brief_title": "Phase III HIV/HCV Co-Infection Daclatasvir (DCV)+ Sofosbuvir (SOF)", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hepatitis C", 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis C"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "For more information regarding BMS clinical trial participation, please visit\n        www.BMSStudyConnect.com\n\n        Inclusion Criteria:\n\n          -  Subjects must be able to understand and agree to comply with the prescribed dosing\n             regimens and procedures, report for regularly scheduled study visits, and reliably\n             communicate with study personnel about adverse events and concomitant medications\n\n          -  Subjects chronically infected with HCV genotype 1, 2, 3, 4, 5 or 6, as documented by\n             positive HCV RNA at screening\n\n          -  HCV-Treatment-naive subjects\n\n          -  HCV treatment-experienced subjects are eligible. All permitted prior anti-HCV\n             therapies must be discontinued or completed at least 12 weeks prior to screening\n\n          -  Subjects must have an HCV RNA \u2265 10,000 IU/mL at Screening\n\n          -  Subjects must have HIV-1 infection\n\n        Exclusion Criteria:\n\n          -  Presence of acquired immunodeficiency syndrome (AIDS)-defining opportunistic\n             infections within 12 weeks prior to study entry (AIDS-defining opportunistic\n             infections as defined by the CDC)\n\n          -  Subjects infected with HIV-2\n\n          -  Liver or any other organ transplant (including hematopoietic stem cell transplants)\n             other than cornea and hair\n\n          -  Current or known history of cancer (except in situ carcinoma of the cervix or\n             adequately treated basal or squamous cell carcinoma of the skin) within 5 years prior\n             to screening\n\n          -  Documented or suspected hepatocellular carcinoma (HCC), as evidenced by previously\n             obtained imaging studies or liver biopsy (or on a screening imaging study/liver\n             biopsy if this was performed)\n\n          -  Evidence of decompensated liver disease including, but not limited to, radiologic\n             criteria,a history or presence of ascites, bleeding varices, or hepatic\n             encephalopathy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02032888", 
            "org_study_id": "AI444-216"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Arm 1: Cohort 1a-Treatment-naive-12 weeks", 
                    "Arm 2: Cohort 1b-Treatment-naive-8 weeks", 
                    "Arm 3: Cohort 2-Treatment Experineced-12 weeks"
                ], 
                "intervention_name": "Daclatasvir", 
                "intervention_type": "Drug", 
                "other_name": "BMS-790052"
            }, 
            {
                "arm_group_label": [
                    "Arm 1: Cohort 1a-Treatment-naive-12 weeks", 
                    "Arm 2: Cohort 1b-Treatment-naive-8 weeks", 
                    "Arm 3: Cohort 2-Treatment Experineced-12 weeks"
                ], 
                "intervention_name": "Sofosbuvir", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 27, 2014", 
        "link": [
            {
                "description": "BMS Clinical Trial Information", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "BMS clinical trial educational resource", 
                "url": "http://www.bms.com/studyconnect/Pages/home.aspx"
            }, 
            {
                "description": "Investigator Inquiry form", 
                "url": "http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"
            }, 
            {
                "description": "FDA Safety Alerts and Recalls", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "University Of Alabama At Birmingham"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beverly Hills", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90211"
                    }, 
                    "name": "Pacific Oaks Medical Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90822"
                    }, 
                    "name": "Va Long Beach Healthcare System"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90036"
                    }, 
                    "name": "Peter J Ruane Md Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90069"
                    }, 
                    "name": "Anthony M. Mills Md Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90232"
                    }, 
                    "name": "Jeffrey Goodman Special Care Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92114"
                    }, 
                    "name": "Precision Research Institute, Llc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103"
                    }, 
                    "name": "Ucsd Antiviral Research Center (Avrc)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94110"
                    }, 
                    "name": "University Of California San Francisco"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aurora", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80045"
                    }, 
                    "name": "University Of Colorado"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20010"
                    }, 
                    "name": "Medstar Washington Hospital Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20009"
                    }, 
                    "name": "Whitman Walker Health"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20036"
                    }, 
                    "name": "Capital Medical Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Pierce", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34982"
                    }, 
                    "name": "Midway Immunology And Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "University Of Miami Schiff Center For Liver Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32803"
                    }, 
                    "name": "Orlando Immunology Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30033"
                    }, 
                    "name": "Infect. Disease Specialists"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Indiana University Health - University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21229"
                    }, 
                    "name": "Digestive Disease Associates, P.A."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lutherville", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21093"
                    }, 
                    "name": "Johns Hopkins University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }, 
                    "name": "Henry Ford Health System"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63110"
                    }, 
                    "name": "Washington University School Of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sante Fe", 
                        "country": "United States", 
                        "state": "New Mexico", 
                        "zip": "87505"
                    }, 
                    "name": "Southwest Care Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Binghamton", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13903"
                    }, 
                    "name": "Binghamton Gastroenterology Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Icahn School Of Medicine At Mount Sinai"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45267"
                    }, 
                    "name": "University Of Cincinnati"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tulsa", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "74135"
                    }, 
                    "name": "Healthcare Research Consultants"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97239"
                    }, 
                    "name": "Oregon Health Science Univ"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Allentown", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "18102"
                    }, 
                    "name": "Lehigh Valley Health Network"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Providence", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02906"
                    }, 
                    "name": "The Miriam Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Providence", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02905"
                    }, 
                    "name": "University Gastroenterology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Worth", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76104"
                    }, 
                    "name": "Tarrant County Inf Dis Assoc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77004"
                    }, 
                    "name": "Cure C Consortium"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "University Of Texas Health Science Center At Houston"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Murray", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84123"
                    }, 
                    "name": "Clinical Research Centers Of America"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23249"
                    }, 
                    "name": "Mcguire D V A M C"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98104"
                    }, 
                    "name": "Harborview Medical Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-na\u00efve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)", 
        "overall_official": {
            "affiliation": "Bristol-Myers Squibb", 
            "last_name": "Bristol-Myers Squibb", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "SVR12 defined as hepatitis C virus (HCV) ribonucleic acid (RNA) < lower limit of quantification (LLOQ) target detected (TD) or target not detected (TND) at follow-up Week 12 for the treatment-naive HCV genotype 1 subjects coinfected with HIV on the DCV+SOF 12-week regimen", 
            "measure": "Proportion of treatment-naive subjects with sustained virologic response 12 (SVR12)", 
            "safety_issue": "No", 
            "time_frame": "Post treatment Week 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02032888"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "SVR12 defined as hepatitis C virus (HCV) ribonucleic acid (RNA) < lower limit of quantification (LLOQ) target detected (TD) or target not detected (TND) at follow-up Week 12 for the treatment-naive HCV genotype 1 subjects coinfected with HIV on the DCV+SOF 8 -week regimen", 
                "measure": "Proportion of treatment-naive subjects with SVR12", 
                "safety_issue": "No", 
                "time_frame": "Post treatment Week 12"
            }, 
            {
                "description": "SVR12 defined as hepatitis C virus (HCV) ribonucleic acid (RNA) < lower limit of quantification (LLOQ) target detected (TD) or target not detected (TND) at follow-up Week 12 for the treatment-experienced HCV genotype 1 subjects coinfected with HIV on the DCV+SOF 12-week regimen", 
                "measure": "Proportion of treatment-experienced HCV subjects with SVR12", 
                "safety_issue": "No", 
                "time_frame": "Post treatment Week 12"
            }, 
            {
                "description": "SVR12 defined as HCV RNA < LLOQ TD or TND at follow-up Week 12 without regard to infecting HCV genotype", 
                "measure": "Proportion of HIV/HCV coinfected subjects, in each treatment arm, with SVR12", 
                "safety_issue": "No", 
                "time_frame": "Post treatment Week 12"
            }, 
            {
                "description": "EOT = End of treatment", 
                "measure": "Safety measured by deaths and the frequency of serious adverse events (SAEs), discontinuations due to adverse events (AEs), Grade 3/4 AEs, and Grade 3/4 laboratory abnormalities", 
                "safety_issue": "Yes", 
                "time_frame": "Up to EOT (Approximately 8/12 weeks depending on treatment regimen) + 7 days"
            }, 
            {
                "measure": "The proportion of subjects coinfected with HIV, in each treatment arm, who achieve HCV RNA < LLOQ-TD/TND", 
                "safety_issue": "No", 
                "time_frame": "At Weeks: 1, 2, 4, 6, 8 and 12 (for subjects in the 12-week arm) and EOT; post-treatment Weeks 4 and 24"
            }, 
            {
                "measure": "The proportion of subjects coinfected with HIV, in each treatment arm, who achieve HCV RNA < LLOQ TND", 
                "safety_issue": "No", 
                "time_frame": "At Weeks: 1, 2, 4, 6, 8 and 12 (for subjects in the 12-week arm) and EOT"
            }, 
            {
                "measure": "The proportion of HIV/HCV coinfected subjects, in each treatment arm, with CC or non-CC genotype at the IL28B rs12979860 single nucleotide polymorphisms (SNPs) who achieve SVR12", 
                "safety_issue": "No", 
                "time_frame": "Post treatment Week 12"
            }
        ], 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}